Which statement about dyslipidemia risk by FGAs potency is most accurate?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Master HIV/AIDS Antiretroviral Therapy Test with comprehensive flashcards and multiple-choice questions. Each question provides detailed explanations to enhance your knowledge. Prepare effectively and excel in your exam!

Multiple Choice

Which statement about dyslipidemia risk by FGAs potency is most accurate?

Explanation:
Higher-potency FGAs have stronger pharmacologic effects at D2 receptors, and this stronger blockade tends to disturb metabolic processes more, leading to a greater risk of dyslipidemia. While metabolic side effects are most famous with second-generation antipsychotics, among FGAs the trend is that higher potency agents—used at lower doses to achieve antipsychotic effects—are more likely to be associated with lipid disturbances than lower potency ones. That’s why the statement that risk increases with potency, with high-potency agents having the highest risk, best fits the observed relationship.

Higher-potency FGAs have stronger pharmacologic effects at D2 receptors, and this stronger blockade tends to disturb metabolic processes more, leading to a greater risk of dyslipidemia. While metabolic side effects are most famous with second-generation antipsychotics, among FGAs the trend is that higher potency agents—used at lower doses to achieve antipsychotic effects—are more likely to be associated with lipid disturbances than lower potency ones. That’s why the statement that risk increases with potency, with high-potency agents having the highest risk, best fits the observed relationship.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy